A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children.
- Submitting institution
-
London School of Hygiene and Tropical Medicine
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 822
- Type
- D - Journal article
- DOI
-
10.1016/j.vaccine.2016.07.041
- Title of journal
- Vaccine
- Article number
- -
- First page
- 4536
- Volume
- 34
- Issue
- 38
- ISSN
- 0264-410X
- Open access status
- Compliant
- Month of publication
- July
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
17
- Research group(s)
-
-
- Citation count
- 44
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- No contributions statement in paper. Author's Statement: Other listed author; conception and design of the study, organisation of the conduct of the study, analysis and interpretation of the data; helped draft the output, helped critique the output for important intellectual content
- Non-English
- No
- English abstract
- -